These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

235 related items for PubMed ID: 6580841

  • 1. [Phase II study of vindesine in hematological malignancies].
    Gan To Kagaku Ryoho; 1983 Dec; 10(12):2509-15. PubMed ID: 6580841
    [Abstract] [Full Text] [Related]

  • 2. A phase II study of vindesine in patients with hematological malignancies.
    Hulhoven R, Michaux JL, Cornu G, Ferránt A, Bosly A, Delannoy A, Sokal G.
    Biomedicine; 1980 Apr; 33(2):31-2. PubMed ID: 6931617
    [Abstract] [Full Text] [Related]

  • 3. [Administration of vindesine sulfate for the treatment of malignant hematological tumors].
    Ueda T, Masaoka T, Shibata H, Kubota Y, Saigo K, Kusakabe H, Takubo T, Nakamura H, Yoshitake J, Ishigami S.
    Gan To Kagaku Ryoho; 1982 Feb; 9(2):306-15. PubMed ID: 6764103
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Continuous 5-day vindesine in the treatment of leukemias and lymphomas (author's transl)].
    Maraninchi D, Gastaut JA, Tubiana N, Carcassonne Y.
    Bull Cancer; 1981 Feb; 68(4):338-42. PubMed ID: 6947833
    [Abstract] [Full Text] [Related]

  • 7. [Leukaemias and lymphomas treatment by vindesine. Result of a phase II trial in terms of remission induction (author's transl)].
    Marthé G, Misset JL, de Vassal F, Hayat M, Gouveia J, Machover D, Belpomme D, Schwarzenberg L, Ribaud P, Pico JL, Musset M, Jasmin C, de Luca L.
    Nouv Presse Med; 1978 Feb 18; 7(7):525-8. PubMed ID: 273888
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Phase II study of Vindesine in patients with hematological malignancy].
    Sampi K, Honda T, Hayashi Y, Hattori M.
    Gan To Kagaku Ryoho; 1983 Jun 18; 10(6):1536-7. PubMed ID: 6347082
    [Abstract] [Full Text] [Related]

  • 10. Phase-II trial with vindesine for regression induction in patients with leukemias and hematosarcomas.
    Bayssas M, Gouveia J, Ribaud P, Musset M, de Vassal F, Pico JL, de Luca L, Misset JL, Machover D, Belpomme D, Schwarzenberg L, Jasmin C, Hayat M, Mathé G.
    Cancer Chemother Pharmacol; 1979 Jun 18; 2(4):247-55. PubMed ID: 287569
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. m-AMSA: phase II trial in advanced lymphoma and leukemia.
    Case DC.
    Am J Clin Oncol; 1984 Aug 18; 7(4):357-60. PubMed ID: 6588746
    [Abstract] [Full Text] [Related]

  • 13. Phase II trial of vindesine in the treatment of lymphomas, breast cancer, and other solid tumors.
    Miller TP, Jones SE, Chester A.
    Cancer Treat Rep; 1980 Aug 18; 64(8-9):1001-3. PubMed ID: 7448818
    [Abstract] [Full Text] [Related]

  • 14. Vindesine in the treatment of refractory hematologic malignancies: a phase II study.
    Mandelli F, Amadori S, Giona F, Antonietta M, Spiriti A, Pastore S, Meloni G, Paolucci G.
    Leuk Res; 1982 Aug 18; 6(5):649-52. PubMed ID: 7154707
    [Abstract] [Full Text] [Related]

  • 15. Phase II clinical trial with vindesine for remission induction in acute leukemia, blastic crisis of chronic myeloid leukemia, lymphosarcoma, and hodgkin's disease: absence of cross-resistance with vincristine.
    Mathé G, Misset JL, De Vassal F, Gouveia J, Hayat M, Machover D, Belpomme D, Pico JL, Schwarzenberg L, Ribaud P, Musset M, Jasmin C, De Luca L.
    Cancer Treat Rep; 1978 May 18; 62(5):805-9. PubMed ID: 274996
    [Abstract] [Full Text] [Related]

  • 16. Treatment of chronic myeloid leukemia blast crisis with vindesine and prednisone.
    Jehn U, Mezger J.
    Cancer Treat Rep; 1985 Apr 18; 69(4):445-8. PubMed ID: 3857971
    [Abstract] [Full Text] [Related]

  • 17. Phase II study of vindesine in patients with advanced breast cancer.
    Walker BK, Raich PC, Fontana J, Subramanian VP, Rogers JS, Knost JA, Denning B.
    Cancer Treat Rep; 1982 Sep 18; 66(9):1729-32. PubMed ID: 6288237
    [Abstract] [Full Text] [Related]

  • 18. Vindesine in the treatment of esophageal carcinoma: a phase II study.
    Kelsen DP, Bains M, Cvitkovic E, Golbey R.
    Cancer Treat Rep; 1979 Sep 18; 63(11-12):2019-21. PubMed ID: 526935
    [Abstract] [Full Text] [Related]

  • 19. [Therapy of the blast crisis in chronic myeloid leukemia. Results of a phase II study with vindesine].
    Hellriegel KP.
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1981 Sep 18; 108(5):699-706. PubMed ID: 6172337
    [No Abstract] [Full Text] [Related]

  • 20. [Phase II trial of mitoxantrone in patients with relapsed and refractory acute leukemia].
    Sampi K, Ogawa M, Kimura I, Ohnoshi T, Yamada K, Masaoka T, Wakui A, Meguro S, Nagai K, Kitani T.
    Gan To Kagaku Ryoho; 1986 Oct 18; 13(10):3021-7. PubMed ID: 3464230
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.